You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

CLINICAL TRIALS PROFILE FOR RITANSERIN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Ritanserin

Trial IDTitleStatusSponsorPhaseSummary
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000187 ↗ Ritanserin in Treatment of Cocaine Dependence - 1 Completed University of Pennsylvania Phase 2 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00206765 ↗ Risperidone vs. Paroxetine for Panic Attacks Terminated Beth Israel Medical Center Phase 2 We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.
NCT00457106 ↗ A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks Completed Beth Israel Medical Center N/A This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of risperidone vs. paroxetine in treatment of panic attacks and compares response rates of risperidone vs. paroxetine in treatment of panic attacks.
>Trial ID>Title>Status>Phase>Summary
Showing 1 to 4 of 4 entries

Clinical Trial Conditions for Ritanserin

Condition Name

21110-0.200.20.40.60.811.21.41.61.822.2Panic DisorderMajor Depression With Panic AttacksMajor Depressive Disorder With Panic AttacksCocaine-Related Disorders[disabled in preview]
Condition Name
Intervention Trials
Panic Disorder 2
Major Depression With Panic Attacks 1
Major Depressive Disorder With Panic Attacks 1
Cocaine-Related Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

22110-0.200.20.40.60.811.21.41.61.822.2Panic DisorderDepressive Disorder, MajorDiseaseDepressive Disorder[disabled in preview]
Condition MeSH
Intervention Trials
Panic Disorder 2
Depressive Disorder, Major 2
Disease 1
Depressive Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ritanserin

Trials by Country

+
Trials by Country
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State
Location Trials
New York 2
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ritanserin

Clinical Trial Phase

66.7%33.3%0-0.200.20.40.60.811.21.41.61.822.2Phase 2N/A[disabled in preview]
Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

66.7%33.3%0-0.200.20.40.60.811.21.41.61.822.2CompletedTerminated[disabled in preview]
Clinical Trial Status
Clinical Trial Phase Trials
Completed 2
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ritanserin

Sponsor Name

trials000111112222Beth Israel Medical CenterUniversity of PennsylvaniaNational Institute on Drug Abuse (NIDA)[disabled in preview]
Sponsor Name
Sponsor Trials
Beth Israel Medical Center 2
University of Pennsylvania 1
National Institute on Drug Abuse (NIDA) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

75.0%25.0%000.511.522.53OtherNIH[disabled in preview]
Sponsor Type
Sponsor Trials
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.